Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 13 Prostatic Neoplasms 9 Carcinoma, Hepatocellular 8 Liver Neoplasms 6 Neoplasm Metastasis 3 Melanoma 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Unresectable Pancreatic Cancer 2 Stomach Neoplasms 2 Squamous Intraepithelial Lesions 2 Neoplasms 2 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Kidney Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Pancreatic Adenocarcinoma Locally Advanced 1

Interventions

Cisplatin 35 Radiotherapy 20 Magnetic Resonance Spectroscopy 19 Cetuximab 17 Specimen Handling 15 pembrolizumab 13 Carboplatin 13 Radiotherapy, Intensity-Modulated 12 Fluorouracil 12 Docetaxel 12 1,2-diaminocyclohexaneplatinum II citrate 10 Radiation 9 Platinum 9 Paclitaxel 8 Surgical Procedures, Operative 7 Drug Therapy 6 Biopsy 6 Taxes 5 toripalimab 4 X-Rays 4 Standard of Care 4 Fluorodeoxyglucose F18 4 Celecoxib 4 (225)Ac-DOTA-c(RGDyK) 4 cemiplimab 3 Nutritional Status 3 Laser Therapy 3 Interviews as Topic 3 Hydroxyurea 3 130-nm albumin-bound paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Laryngeal Neoplasms × Electroporation × Clear all

NCT02430675 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡